Acquired
Novo Nordisk (Ozempic)
David Rosenthal
Novo has next-generation GLP-1 drugs in the pipeline themselves. Cagrasema is the big one that they're currently working on that they think will be as good, if not better, than what Eli Lilly has with Terzibetide. So I think we're basically just assuming that everything continues to be proven safe in the long run.
0
💬
0
Comments
Log in to comment.
There are no comments yet.